Published in Vaccine Weekly, April 3rd, 1995
By the end of 1994, the Recombinant DNA Advisory Committee (RAC) had approved 42 trials related to gene insertion as a cancer therapeutic and cancer vaccines, reports Gail Dutton in the March 1, 1995, issue of Genetic Engineering News. Following is a partial list of companies conducting research and clinical trials in the area of cancer gene therapy and cancer vaccines:
Canji, based in San...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly